Results 271 to 280 of about 30,954,665 (307)
Some of the next articles are maybe not open access.

Type 2 diabetes mellitus in adolescents

Current Opinion in Pediatrics, 2000
Type 2 diabetes mellitus, a significant cause of adult morbidity and mortality, is being diagnosed more frequently in children and adolescents. Genetic predisposition and environmental factors are important determinants for the expression of this disease.
S T, Callahan, M J, Mansfield
openaire   +2 more sources

Dyslipidemia in type 2 diabetes mellitus

Nature Reviews Endocrinology, 2009
Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles.
openaire   +2 more sources

Pathogenesis of Type 2 Diabetes Mellitus

Archives of Medical Research, 2005
The pathological sequence for type 2 diabetes is complex and entails many different elements that act in concert to cause that disease. This review proposes a sequence of events and how they interact by a careful analysis of the human and animal model literature.
openaire   +2 more sources

Type 2 Diabetes Mellitus in Children

Endocrine Practice, 1998
To provide an overview of type 2 diabetes in children and discuss short-term and long-term management strategies.We review the distinction among various types of diabetes mellitus as they apply to children. In addition, we discuss determining the precise diagnosis between the two major variants--type 1 and type 2 diabetes--and clinical management of ...
J H, Pohl, J A, Greer, K S, Hasan
openaire   +2 more sources

Liraglutide for type 2 diabetes mellitus

Expert Opinion on Biological Therapy, 2011
Prevalence of type 2 diabetes mellitus (T2DM) is increasing. Management of this condition and minimizing the cardiovascular risks associated with it poses a significant burden on healthcare resources across the world. Currently available therapeutic agents are effective in glycemic management; however, the majority of these are associated with ...
Kela, R, Khunti, K, Davies, MJ
openaire   +3 more sources

The Prevention of Type 2 Diabetes Mellitus

Endocrinology and Metabolism Clinics of North America, 2005
With a worldwide pandemic of type 2 diabetes upon us, it is imperative that effective and practical preventive strategies be developed for this disease which, once established, carries with it excess morbidity and mortality. This article reviews recently published data on the prevention of type 2 diabetes and compares the demonstrated effectiveness of ...
Silvio E, Inzucchi, Robert S, Sherwin
openaire   +2 more sources

Genes and Type 2 Diabetes Mellitus

Archives of Medical Research, 2005
Type 2 diabetes (T2DM) comprises a group of entities with different genetic causes. In most patients, T2DM results from alterations of various genes, each having a partial and additive effect. The inheritance pattern is thus complex, and environmental factors play an important role in favoring or delaying the expression of the disease.
openaire   +2 more sources

[Insulin and type 2 diabetes mellitus].

Therapeutische Umschau. Revue therapeutique, 2009
Worldwide an increasing number of persons suffers from type 2 diabetes. Often treatment with oral hypoglycemic agents is not sufficient for adequate glycemic control and additional insulin treatment is necessary. Treatment with insulin is recommended if HbA1c levels below 7% cannot be achieved despite lifestyle measures and the proper use of oral ...
Lanker, Andrea Daniela   +2 more
openaire   +2 more sources

Hyperuricaemia and type 2 diabetes mellitus

Clinical and Experimental Pharmacology and Physiology, 2018
SummaryChoi et al reported the effect of hyperuricaemia on the new‐onset type 2 diabetes mellitus (T2DM). I present three queries. (i) Insulin is considered to stimulate uric acid reabsorption via specific transporter and the effect of hyperuricaemia on the new‐onset T2DM should be evaluated by considering insulin resistance. (ii) There is a limitation
openaire   +2 more sources

Type 2 Diabetes Mellitus

Diabetes Technology & Therapeutics, 2000
E, Moghissi, J, Mestman
openaire   +2 more sources

Home - About - Disclaimer - Privacy